[1] Shuang W, Qiao JZ, Jian L, et al.In vivo effects of activation and blockade of 5-HT2A/2C receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease[J].Exp Neurol, 2009, 219(1): 239-248.

[2] Amanda JR, Peter BH.The 5-HT₇ receptor in learning and memory[J].Hippocampus, 2012, 22(4): 762-771.

[3] Recio P, Barahona MV, Orensanz LM, et al.5-hydroxytryptamine induced relaxation in the pig urinary bladder neck [J].Br J Pharmacol, 2009, 157(2): 271-280.

[4] Moran AE, Ayala AE, GallegosE, et al.Effects of systemic administration or intrabursal injection of serotonin on puberty, first ovulation and follicular development in rats[J].Reprod Fert Develop, 2012, 25(8): 1105-1114.

[5] Horiguchi M, Huang M, Meltzer HY.The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats [J].JPET, 2011, 338(2): 605-614.

[6] Thomas DR, Hagan JJ.5-HT₇ receptors [J].Curr Drug Targets CNS Neurol Disord, 2004, 3(1): 81-90.

[7] Costa L, Trovato C, Musumeci SA, et al.5-HT1A and 5-HT₇ receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission [J].Hippocampus, 2012, 22(4): 790-801.

[8] Paxinos G, Watson C.Chemoarchitectonic atlas of the rat brain [M].Amsterdam:Elsevier Press, 2009: 375.

[9] Chen L, Yung KK, Chan YS, et al.5-HT excites globus pallidus neurons by multiple receptor mechanisms[J].Neuroscience, 2008, 151(2): 439-451.

[10] Beique JC, Chapin-Penick EM, Mladenovic L, et al.Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex[J].J Physiol, 2004, 556(Pt 3): 739-754.

[11] Matsumoto M, Kojima T, Togashi H, et al.Differential characteristics of endogenous serotonin-mediated synaptic transmission in the hippocampal CA1 and CA3 fields of anaesthetized rats[J].Naunyn Schmiedebergs Arch Pharmacol, 2002, 366(6): 570-577.

[12] Peter BH.The 5-HT₇ receptor and disorders of the nervous system: an overview[J].J Psychopharmacol, 2009, 206(3): 345-354.

[13] Gill CH, Soffin EM, Hagan JJ, et al.5-HT₇ receptors modulate synchronized network activity in rat hippocampus[J].Neuropharmacology, 2002, 42(1): 82-92.

[14] Kaya AH, Vlamings R, Tan S, et al.Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats[J].Brain Res, 2008, 1221(1): 93-97.

[15] Unque C, Ramirez-Ruiz B, Tolosa E, et al.Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia[J].Mov Disord, 2005, 20(5): 540-544.

[16] Jordan K, Hinke A, Grothey A, et al.A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis[J].Support Care Cancer, 2007, 15(9): 1023-1033.

[17] Santana N, Bortolozzi A, Serrats J, et al.Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex[J].Cereb Cortex, 2004, 14(10): 1100-1109.

[18] Tadashi I, Tomoko H, Kumiko T, et al.Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine-7 (5-HT₇) and 5-HT1A receptor activity[J].JPET, 2010, 334(1): 171-181.

[19] Fan LL, Zhang QJ, Liu J, et al.In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study[J].Neuroscience, 2011, 190(5): 328-338.